EAACI Congress 2024
BackTPS42 - Allergen immunotherapy 4
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis
Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy
Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma
Is the use of anti-hypertensive medication safe during hymenoptera venom immunotherapy?
Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy
